Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
posted on
Mar 31, 2020 07:07PM
Tada,
I am assuming a large enough upfront payment so that RVX no longer needs to worry about paying their bills for the next 2 to 3 years. C$3 million/month = US$50 million (3 months = US$75 million; peanuts for a partner who will get to buy RVX at a throwaway price in 2 or 3 years).
But that is not going to do much for the share price. It will stilll remain dead money. Market will just give up on RVX as there will no event left to hang your hat on anymore. The next event is years away.
Just my 2 cents.
Iconoclast